Capucine Bouchard

Nordex catches a tailwind, Sainsbury heads into a downdraft

Europe's equity markets are getting a lift from the green energy sector, led by a spectacular jump in Nordex. By contrast, a barrage of negative calls is washing out hopes for Sainsbury, Mycronic and NCAB.

April 27, 2026 at 11:57 am

Forvia: Apollo poised to acquire interiors business for EUR1.4bn

Private equity giant Apollo Global Management is reportedly nearing a deal to acquire the interiors division of French automotive supplier Forvia.

April 23, 2026 at 01:22 pm

The Price of Patience

Following the post-Covid euphoria, Roche is entering a transition phase. Between patent erosion and the need to reignite innovation, the Swiss Pharma giant must prove that it can still create value beyond its past successes.

April 23, 2026 at 01:17 pm

L'Oreal shines, BioMerieux loses momentum

Earnings season is in full swing: L'Oreal is radiant following a record first quarter, while STMicroelectronics electrifies the market by announcing a major return in demand. Conversely, BioMerieux and Sainsbury plunge into the red following guidance revisions.

April 23, 2026 at 12:15 pm

Forvia: Apollo poised to acquire interiors business for 1.4 billion euros

Private equity giant Apollo Global Management is reportedly nearing a deal to acquire the interiors division of French automotive supplier Forvia.

April 23, 2026 at 11:38 am

STMicroelectronics turns up the power, Royal Unibrew wakes up with a hangover

Puig jumps on takeover rumors involving Estée Lauder, while Theon International and STMicroelectronics benefit from brighter prospects. Royal Unibrew, meanwhile, collapses after its love affair with PepsiCo ends, and AB Foods disappoints by announcing the costly spin-off of Primark.

April 21, 2026 at 12:13 pm

Market Odds and Ends: Poland now holds more gold than the ECB

Record gold accumulation in Poland, Taiwan overtaking London, persistent oil tensions and a retreating dollar: a look back at the movements shaking the markets.

April 16, 2026 at 07:01 pm

Siemens Energy: An overpriced success story?

Born from the spin-off of the Siemens conglomerate, Siemens Energy has emerged as one of the most compelling European equity stories in recent years. Driven by the energy transition and the surge in electrical infrastructure requirements linked to AI, the group is benefiting from a powerful narrative tailwind. However, after such a meteoric rise, the question of valuation is now taking center stage.

April 16, 2026 at 12:22 pm

Tesco Hungry for More, Exail Lowers Its Guard

Earnings season is pressing on under the banner of resilience for Britain’s giants: Morgan Sindall surges after raising its targets and Tesco reassures on inventories despite geopolitical tensions. By contrast, the defense sector and industrial tech are posting a clear pullback.

April 16, 2026 at 12:10 pm

Intertek certifies its growth, LVMH loses its luster

Earnings season is officially underway, bringing its share of surprises. Intertek is soaring following the announcement of rising sales, while Eurofins and Stellantis are engaging in strategic rebalancing to reassure markets. Conversely, Scatec is suffering from a divestment by Equinor, and LVMH is attempting to limit the fallout.

April 14, 2026 at 12:10 pm

Robertet follows its nose, Sodexo loses its appetite

Shelly Group soars following its inclusion in the SDax, while Robertet impresses with rising profits and Exail Technologies capitalizes on fresh commercial success. Conversely, Sodexo collapses after a drastic downward revision of its targets, as the oil sector remains weighed down by persistent headwinds.

April 10, 2026 at 11:55 am

Explainer: If I make money on the stock market, has someone else lost it?

The stock market is often imagined as a game where one person's gain is another's loss. This is an intuitive but incomplete view. Depending on the time horizon and the instruments used, the market can also be a powerful engine for wealth creation.

April 09, 2026 at 03:53 pm

Investor education: if I make money in the stock market, did someone else lose it?

The stock market is often imagined as a game where one person's gains are another's losses. It's an intuitive view, but an incomplete one. Depending on the time horizon and the instruments used, markets can also create wealth.

April 09, 2026 at 12:54 pm

Bolloré entities soar, Stellantis and Leonardo under close watch

Universal Music Group surges following Pershing Square's buyout offer, pulling Vivendi and Bolloré higher in its wake, while BW Energy secures its future in Gabon through 2053. Conversely, ASML retreats under the pressure of U.S. restrictions on China, and Stellantis faces heat from the Canadian government.

April 07, 2026 at 12:09 pm

Luxury sector under pressure at the start of 2026

Since January 1, major luxury stocks have fallen sharply across the markets. From LVMH to Hermès, including Richemont and Kering, all are posting double-digit declines. Against a backdrop of geopolitical tensions and a global slowdown in demand, the sector is no longer a "Must Have."

April 02, 2026 at 07:48 pm

Alstom gains momentum, Inventiva underperforms

Südzucker soars following a dramatic turnaround by Barclays, while Alstom accelerates on the back of a major 700 million euro contract. SoftwareOne attracts investors with its profitability. Conversely, Inventiva collapses under the weight of mounting losses, and Clariant faces pressure from a Goldman Sachs downgrade as the pharmaceutical sector remains strained.

March 31, 2026 at 12:22 pm

When AI fear reveals market irrationality

In mid-February, a US small-cap, Algorhythm Holdings, triggered an unexpected shockwave across the markets. Following a communication regarding the performance of its AI-based logistics solution, nearly $17bn in valuation was wiped out in a single session within the transport sector. The Financial Times revisits this episode.

March 30, 2026 at 05:58 pm

Novartis to Acquire Excellergy to Bolster Immunology Pipeline

On Friday Novartis announced an agreement to acquire the US biotech firm. Excellergy, a specialist in next-generation therapies targeting IgE-mediated diseases, in a deal valued at up to $2bn.

March 27, 2026 at 03:25 pm

Novartis announces the acquisition of Excellergy to bolster its immunology franchise

Novartis said Friday it has signed an agreement to acquire U.S. biotech Excellergy, which specializes in next-generation therapies targeting IgE immunoglobulin-related diseases, in a deal valued at up to $2bn.

March 27, 2026 at 01:48 pm

Pernod Ricard cheers merger talks, Dino Polska stumble

Sol S.P.A. rallies on record results and Sobi gains from a price target hike, while a potential alliance between Pernod Ricard and Brown-Forman revitalizes the spirits sector. Conversely, CTS Eventim plunges following disappointing earnings and Dino Polska collapses as margins come under pressure, while Jungheinrich suffers from a slowdown in industrial orders.

March 27, 2026 at 01:21 pm

Henkel bolsters premium hair care portfolio with acquisition of Olaplex

Henkel is pressing ahead with its premiumization strategy, announcing the acquisition of Olaplex for $1.4bn. This transformative deal increases the group's exposure to the upmarket hair care segment and strengthens its Consumer Brands division.

March 26, 2026 at 01:42 pm